Open AccessIndications and Efficacy of Converting From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma.
Author(s) -
Richard J. Hendrickson,
Daniel James,
Walter S. Andrews,
Ryan T. Fischer,
Michelle Manalang,
Shawna Ricks
Publication year - 2014
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-201407151-02458
Subject(s) - hepatoblastoma , sirolimus , medicine , tacrolimus , immunosuppression , liver transplantation , transplantation , gastroenterology , urology , surgery